Vimarsana
Biggest News Aggregation in the World

Page 11 - Guidelines Panel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Guidelines Panel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Guidelines Panel Today - Breaking & Trending Today

The FDA's rejection of fluvoxamine as a Covid drug, explained - Vimarsana News

The FDA's rejection of fluvoxamine as a Covid drug, explained

The FDA made a reasonable decision — but one that still shows much of what’s wrong with our current system for emergency approvals.

Source: vox.com
US Regulators Reject Request to Clear Cheap Drug for Treatment of COVID-19 - Vimarsana News

US Regulators Reject Request to Clear Cheap Drug for Treatment of COVID-19

U.S. regulators have rejected a request to grant emergency authorization to a cheap drug for the treatment of ...

Federal Panel Recommends Against Using Ivermectin to Treat COVID-19 - Vimarsana News

Federal Panel Recommends Against Using Ivermectin to Treat COVID-19

For the first time, a federal health panel recommended against the use of ivermectin for the treatment of ...

WHO backs Paxlovid for milder COVID-19 cases; users tell of odd rebound symptoms - Vimarsana News

WHO backs Paxlovid for milder COVID-19 cases; users tell of odd rebound symptoms

The WHO's guidance comes as some patients and clinicians report recurring symptoms after patients finish a course of Paxlovid.

These people deserve the credit for the deaths of nearly a million Americans - Vimarsana News

These people deserve the credit for the deaths of nearly a million Americans

The members of COVID-19 Treatment Guidelines Panel of the NIH apparently doesn’t seem to place any value on human life. In this article, I will show several examples of this. At no time is there [...]